Epstein-barr virus stimulates torque teno virus replication: A possible relationship to multiple sclerosis

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Borkosky, Silvia S ^a   Whitley, Corinna ^a   Kopp Schneider, Annette ^a   Hausen, Harald ^a   de Villiers, Ethel Michele ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN; BURKITT LYMPHOMA; CANCER CELL CULTURE; CELL LINE; CELL STRAIN BJAB; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; EPSTEIN BARR VIRUS; GENE AMPLIFICATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POLYMERASE CHAIN REACTION; TORQUE TENO VIRUS; VIRUS GENOME; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS STRAIN; DNA REPLICATION; LYMPHOCYTE; METABOLISM; METHODOLOGY; VIROLOGY; VIRUS GENE;

HUMAN HERPESVIRUS 4; TORQUE TENO VIRUS;

BURKITT LYMPHOMA; CELL LINE; DNA REPLICATION; GENES, VIRAL; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOCYTES; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION; TORQUE TENO VIRUS; TRANSFECTION; VIRUS REPLICATION;

EID: 84857492022     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032160     Document Type: Article

References (101)

1. Lauer K, (1994) The risk of multiple sclerosis in the U.S.A. in relation to sociogeographic features: a factor-analytic study. J Clin Epidemiol 47: 43-48.
2. Sospedra M, Martin R, (2006) Molecular mimicry in multiple sclerosis. Autoimmunity 39: 3-8.
3. Libbey JE, Fujinami RS, (2010) Potential triggers of MS. Results Probl Cell Differ 51: 21-42.
4. Kakalacheva K, Münz C, Lünemann JD, (2011) Viral triggers of multiple sclerosis. Biochim Biophys Acta 1812: 132-140.
5. Sawcer S, Hellenthal G, Pirinen M, Spencer CC, et al. International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium 2 (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476: 214-219.
6. zur Hausen H, (2009) Childhood leukemias and other hematopoietic malignancies: interdependence between an infectious event and chromosomal modifications. Int J Cancer 125: 1764-1770.
7. Granieri E, Casetta I, Tola MR, Ferrante P, (2001) Multiple sclerosis: Infectious hypothesis. Neurol Sci 22: 179-185.
8. Ponsonby AL, van der Mei I, Dwyer T, Blizzard L, Taylor B, et al. (2005) Birth order, infection in early life, and multiple sclerosis. Lancet Neurol 4: 793-794.
9. Ascherio A, Munger K, (2008) Epidemiology of multiple sclerosis: from risk factors to prevention. Semin Neurol 28: 17-28.
10. Banwell B, Krupp L, Kennedy J, Tellier R, Tenembaum S, et al. (2007) Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol 6: 773-781.
11. Thomas T, Banwell B, (2008) Multiple sclerosis in children. Semin Neurol 28: 69-83.
12. Banwell B, Bar-Or A, Arnold DL, Sadovnick D, Narayanan S, et al. (2011) Clinical environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study. Lancet Neurol 10: 436-445.
13. McLaughlin KA, Chitnis T, Newcombe J, Franz B, Kennedy J, et al. (2009) Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis. J Immunol 183: 4067-4076.
14. Chitnis T, Krupp L, Yeh A, Rubin J, Kuntz N, et al. (2011) Pediatric multiple sclerosis. Neurol Clin 29: 481-505.
15. Sips GJ, Chesik D, Glazenburg L, Wilschut J, de Keyser J, et al. (2007) Involvement of morbilliviruses in the pathogenesis of demyelinating disease. Rev Med Virol 17: 223-244.
16. Hosking MP, Lane TE, (2010) The pathogenesis of murine coronavirus infection of the central nervous system. Crit Rev Immunol 30: 119-130.
17. Oleszak EL, Chang JR, Friedman H, Katsetos CD, Platsoucas CD, (2004) Theiler's virus infection: a model for multiple sclerosis. Clin Microbiol Rev 17: 174-207.
18. Alvarez-Lafuente R, Garcia-Montojo M, De Las Heras V, Bartolomé M, Arroyo R, (2007) JC virus in cerebrospinal fluid samples of multiple sclerosis patients at the first demyelinating event. Mult Scler 13: 590-595.
19. Delbue S, Guerini FR, Mancuso R, Caputo D, Mazzioti R, et al. (2007) JC virus viremia in interferon-beta-treated and untreated Italian multiple sclerosis patients and healthy controls. J Neurovirol 13: 73-77.
20. Sotelo J, Ordoñez G, Pineda B, (2007) Varicella-zoster virus at relapse of multiple sclerosis. J Neurol 254: 493-500.
21. Mancuso R, Delbue S, Borghi E, Pagani E, Calvo MG, et al. (2007) Increased prevalence of varicella zoster virus DNA in cerebrospinal fluid from patients with multiple sclerosis. J Med Virol 79: 192-199.
22. Christensen T, (2005) Association of human endogenous retrovirus with multiple sclerosis and possible interactions with herpes viruses. Rev Med Virol 15: 179-211.
23. Brudek T, Lühdorf P, Christensen T, Hansen HJ, Moller-Larsen A, (2007) Activation of endogenous retrovirus reverse transcriptase in multiple sclerosis patient lymphocytes by inactivated HSV-1, HHV-6 and VZV. J Neuroimmunol 187: 147-155.
24. Challoner PB, Smith KT, Parker JD, MacLeod DL, Coulter SN, et al. (1995) Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci USA 92: 7440-7444.
25. Soldan SS, Berti R, Salem N, Secchiero P, Flamand L, et al. (1997) Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat Med 3: 1394-1397.
26. Clark D, (2004) Human herpesvirus type 6 and multiple sclerosis. Herpes 11 (Suppl 2): 112A-119A.
27. Mameli G, Astone V, Arru G, Marconi S, Lovato L, et al. (2007) Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not human herpesvirus 6. J Gen Virol 88: 264-274.
28. Kuusisto H, Hyöty H, Kares S, Kinnunen E, Elovaara I, (2008) Human herpes virus 6 and multiple sclerosis: a Finnish twin study. Mult Scler 14: 54-58.
29. Cassiani-Ingoni R, Greenstone HL, Donati D, Fogdell-Hahn A, Martinelli E, et al. (2005) CD46 on glial cells can function as a receptor for viral glycoprotein-mediated cell-cell fusion. Glia 52: 252-258.
30. Tejada-Simon MV, Zang YC, Hong J, Rivera VM, Zhang JZ, (2003) Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis. Ann Neurol 53: 189-197.
31. Thacker EL, Mirzaei F, Ascherio A, (2006) Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann Neurol 59: 499-503.
32. Handel AE, Williamson AJ, Disanto G, Handunnetthi L, Giovannoni G, et al. (2010) An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis. PLoS ONE 5: e12496.
33. Ascherio A, Munger KL, (2010) Epstein-Barr virus infection and multiple sclerosis: a review. J Neuroimmune Pharmacol 5: 271-277.
34. Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, et al. (2005) Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 293: 2496-2500.
35. Pohl D, Krone B, Rostasy K, Kahler E, Brunner E, et al. (2006) High seroprevalence of Epstein-Barr virus in children with multiple sclerosis. Neurology 67: 2063-2065.
36. Lünemann JD, Münz C, (2009) EBV in MS: guilty by association? Trends Immunol 30: 243-248.
37. Torkildsen O, Nyland H, Myrmel H, Myhr KM, (2008) Epstein-Barr virus reactivation and multiple sclerosis. Eur J Neurol 15: 106-108.
38. Willis SN, Stadelmann C, Rodig SJ, Caron T, Gattenloehner S, et al. (2009) Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain 132: 3318-3328.
39. Peferoen LA, Lamers F, Lodder LN, Gerritsen WH, Huitinga I, et al. (2010) Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis. Brain 133: e137.
40. Sargsyan SA, Shearer AJ, Ritchie AM, Burgoon MP, Anderson S, et al. (2010) Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis. Neurology 74: 1127-1135.
41. Wucherpfennig KW, Strominger JL, (1995) Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80: 695-705.
42. Croxford JL, Olson JK, Anger HA, Miller SD, (2005) Initiation and exacerbation of autoimmune demyelination of the central nervous system via virus-induced molecular mimicry: implications for the pathogenesis of multiple sclerosis. J Virol 79: 8581-8590.
43. Sospedra M, Zhao Y, zur Hausen H, Muraro PA, Hamashin C, et al. (2005) Recognition of conserved amino acid motifs of common viruses and its role in autoimmunity. PLoS Pathog 1: e41.
44. Libbey JE, McCoy LL, Fujinami RS, (2007) Molecular mimicry in multiple sclerosis. Int Rev Neurobiol 79: 127-147.
45. Münz C, Bickham KL, Subklewe M, Tsang ML, Chahroudi A, et al. (2000) Human CD4+ T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1. J Exp Med 191: 1649-1660.
46. Lünemann JD, Edwards N, Muraro PA, Hayashi S, Cohen JI, et al. (2006) Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. Brain 129: 1493-1506.
47. Lünemann JD, Jelcić I, Roberts S, Lutterotti A, Tackenberg B, et al. (2008) EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. J Exp Med 205: 1763-1773.
48. Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, et al. (1997) A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun 241: 92-97.
49. Okamoto H, (2009) History of discoveries and pathogenicity of TT viruses. Curr Top Microbiol Immunol 331: 1-20.
50. Peng YH, Nishizawa T, Takahashi M, Ishikawa T, Yoshikawa A, et al. (2002) Analysis of the entire genomes of thirteen TT virus variants classifiable into the fourth and fifth genetic groups, isolated from viremic infants. Arch Virol 147: 21-41.
51. Ninomiya M, Takahashi M, Nishizawa T, Shimosegawa T, Okamoto H, (2008) Development of PCR assays with nested primers specific for differential detection of three human anelloviruses and early acquisition of dual or triple infection during infancy. J Clin Microbiol 46: 507-514.
52. de Villiers EM, Kimmel R, Leppik L, Gunst K, (2009) Intragenomic rearrangement in TT viruses: a possible role in the pathogenesis of disease. Curr Top Microbiol Immunol 331: 91-107.
53. Biagini P, de Micco P, (2010) La famille des Anelloviridae: virus TTV et genres apparentés. Virologie 14: 3-16.
54. Okamoto H, Kato N, Iizuka H, Tsuda F, Miyakawa Y, et al. (1999) Distinct genotypes of a nonenveloped DNA virus associated with posttransfusion non-A to G hepatitis (TT virus) in plasma and peripheral blood mononuclear cells. J Med Virol 57: 252-258.
55. Jelcic I, Hotz-Wagenblatt A, Hunziker A, zur Hausen H, de Villiers EM, (2004) Isolation of multiple TT virus genotypes from spleen biopsy tissue from a Hodgkin's disease patient: genome reorganization and diversity in the hypervariable region. J Virol 78: 7498-7507.
56. de Villiers EM, Bulajic M, Nitsch C, Kecmanovic D, Pavlov M, et al. (2007) TTV infection in colorectal cancer tissues and normal mucosa. Int J Cancer 121: 2109-2112.
57. Okamoto H, Takahashi M, Kato N, Fukuda M, Tawara A, et al. (2000) Sequestration of TT virus of restricted genotypes in peripheral blood mononuclear cells. J Virol 74: 10236-10239.
58. Maggi F, Fornai C, Zaccaro L, Morrica A, Vatteroni ML, et al. (2001) TT virus (TTV) loads associated with different peripheral blood cell types and evidence for TTV replication in activated mononuclear cells. J Med Virol 64: 190-194.
59. Kanda Y, Tanaka Y, Kami M, Saito T, Asai T, et al. (1999) TT virus in bone marrow transplant recipients. Blood 93: 2485-2490.
60. Okamoto H, Takahashi M, Nishizawa T, Tawara A, Sugai Y, et al. (2000) Replicative forms of TT virus DNA in bone marrow cells. Biochem Biophys Res Commun 270: 657-662.
61. Gergely P Jr, Perl A, Poór G, (2006) Possible pathogenic nature of the recently discovered TT virus: does it play a role in autoimmune rheumatic diseases? Autoimmun Rev 6: 5-9.
62. Blazsek A, Sillo P, Ishii N, Gergely P Jr, Poor G, et al. (2008) Searching for foreign antigens as possible triggering factors of autoimmunity: Torque Teno virus DNA prevalence is elevated in sera of patients with bullous pemphigoid. Exp Dermatol 17: 446-454.
63. Maggi F, Andreoli E, Riente L, Meschi S, Rocchi J, et al. (2007) Torque tenovirus in patients with arthritis. Rheumatology 46: 885-886.
64. Kakkola L, Tommiska J, Boele LC, Miettinen S, Blom T, et al. (2007) Construction and biological activity of a full-length molecular clone of human Torque teno virus (TTV) genotype 6. FEBS J 274: 4719-4730.
65. Leppik L, Gunst K, Lehtinen M, Dillner J, Streker K, et al. (2007) In vivo and in vitro intragenomic rearrangement of TT viruses. J Virol 81: 9346-9356.
66. Müller B, März A, Doberstein K, Finsterbusch T, Mankertz A, (2008) Gene expression of the human Torque Teno Virus isolate P/1C1. Virology 381: 36-45.
67. de Villiers EM, Borkosky SS, Kimmel R, Gunst K, Fei JW, (2011) The diversity of TT viruses: in vitro replication leads to the formation of additional replication-competent subviral molecules. J Virol 85: 7284-7295.
68. Schlehofer JR, Gissmann L, Matz B, zur Hausen H, (1983) Herpes simplex virus-induced amplification of SV40 sequences in transformed Chinese hamster embryo cells. Int J Cancer 32: 99-103.
69. Georg-Fries B, Biederlack S, Wolf J, zur Hausen H, (1984) Analysis of proteins, helper dependence, and seroepidemiology of a new human parvovirus. Virology 134: 64-71.
70. Schlehofer JR, Ehrbar M, zur Hausen H, (1986) Vaccinia virus, herpes simplex virus, and carcinogens induce DNA amplification in a human cell line and support replication of a helpervirus dependent parvovirus. Virology 152: 110-117.
71. Heilbronn R, zur Hausen H, (1989) A subset of herpes simplex virus replication genes induces DNA amplification within the host cell genome. J Virol 63: 3683-3692.
72. Heilbronn R, Albrecht I, Stephan S, Bürkle A, zur Hausen H, (1993) Human cytomegalovirus induces JC virus DNA replication in human fibroblasts. Proc Natl Acad Sci USA 90: 11406-11410.
73. Sugawara Y, Makuuchi M, Kato N, Shimotohno K, Takada K, (1999) Enhancement of hepatitis C virus replication by Epstein-Barr virus-encoded nuclear antigen 1. EMBO J 18: 5755-5760.
74. Leinbach SS, Summers WC, (1979) Herpes simplex virus type 1 infection of isogenic Epstein-Barr virus genome-negative and-positive Burkitt's lymphoma-derived cell lines. J Virol 30: 248-254.
75. Feederle R, Bannert H, Lips H, Müller-Lantzsch N, Delecluse HJ, (2009) The Epstein-Barr virus alkaline exonuclease BGLF5 serves pleiotropic functions in virus replication. J Virol 83: 4952-4962.
76. Hinuma Y, Konn M, Yamaguchi J, Wudarski DJ, Blakeslee JR Jr, et al. (1967) Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line. J Virol 1: 1045-1051.
77. Miller G, Lipman M, (1973) Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc Natl Acad Sci U S A 70: 190-194.
78. Fresen KO, Cho MS, zur Hausen H, (1978) Recovery of transforming EBV from non-producer cells after superinfection with non-transforming P3HR-1 EBV. Int J Cancer 22: 378-383.
79. Germi R, Morand P, Brengel-Pesce K, Fafi-Kremer S, Genoulaz O, et al. (2004) Quantification of gp350/220 Epstein-Barr virus (EBV) mRNA by real-time reverse transcription-PCR in EBV-associated diseases. Clin Chem 50: 1814-1817.
80. zur Hausen H, Schlehofer JR, (1987) The role of DNA amplification in tumor development: prospects from virological studies. In: zur Hausen H, Schlehofer JR, editors. Accomplishments in Oncology Philadelphia Lippincott pp. 126-132.
81. Buck CB, Pastrana DV, Lowy DR, Schiller JT, (2004) Efficient intracellular assembly of papillomaviral vectors. J Virol 78: 751-757.
82. Bornkamm GW, Hammerschmidt W, (2001) Molecular virology of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci 356: 437-459.
83. Canaan A, Haviv I, Urban AE, Schulz VP, Hartman S, et al. (2009) EBNA1 regulates cellular gene expression by binding cellular promoters. Proc Natl Acad Sci USA 106: 22421-22426.
84. d'Hérouel AF, Birgersdotter A, Werner M, (2010) FR-like EBNA1 binding repeats in the human genome. Virology 405: 524-529.
85. Castellazzi M, Tamborino C, Cani A, Negri E, Baldi E, et al. (2010) Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis. Mult Scler 16: 883-887.
86. Levin LI, Munger KL, O'Reilly EJ, Falk KI, Ascherio A, (2010) Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann Neurol 67: 824-830.
87. Comabella M, Montalban X, Horga A, Messmer B, Kakalacheva K, et al. (2010) Antiviral immune response in patients with multiple sclerosis and healthy siblings. Mult Scler 16: 355-358.
88. Lünemann JD, Huppke P, Roberts S, Brück W, Gärtner J, et al. (2008) Broadened and elevated humoral immune response to EBNA1 in pediatric multiple sclerosis. Neurology 71: 1033-1035.
89. Lünemann JD, Tintoré M, Messmer B, Strowig T, Rovira A, et al. (2010) Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis. Ann Neurol 67: 159-169.
90. Waubant E, Mowry EM, Krupp L, Chitnis T, Yeh EA, et al. (2011) Common viruses associated with lower pediatric multiple sclerosis risk. Neurology 76: 1989-1995.
91. Mechelli R, Anderson J, Vittori D, Coarelli G, Annibali V, et al. (2011) Epstein-Barr virus nuclear antigen-1 B-cell epitopes in multiple sclerosis twins. Mult Scler 17: 1290-1294.
92. Garbuglia AR, Iezzi T, Capobianchi MR, Pignoloni P, Pulsoni A, et al. (2003) Detection of TT virus in lymph node biopsies of B-cell lymphoma and Hodgkin's disease, and its association with EBV infection. Int J Immunopathol Pharmacol 16: 109-118.
93. Figueiredo CP, Franz-Vasconcelos HC, Giunta G, Mazzuco TL, Caon T, et al. (2007) Detection of Torque teno virus in Epstein-Barr virus positive and negative lymph nodes of patients with Hodgkin lymphoma. Leuk Lymphoma 48: 731-735.
94. Küppers R, (2003) B cells under influence: transformation of B cells by Epstein-Barr virus. Nature Rev Immunol 3: 801-812.
95. Thorley-Lawson DA, (2001) Epstein-Barr virus: exploiting the immune system. Nature Rev Immunol 1: 75-82.
96. Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, et al. (2007) Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 130: 1089-1104.
97. von Herrath MG, Fujinami RS, Whitton JL, (2003) Microorganisms and autoimmunity: making the barren field fertile? Nat Rev Microbiol 1: 151-157.
98. Klein G, Giovanella B, Westman A, Stehlin JS, Mumford D, (1975) An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection. Intervirology 5: 319-334.
99. Menezes J, Leibold W, Klein G, Clements G, (1975) Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma. Biomedicine 22: 276-284.
100. Fresen KO, zur Hausen H, (1976) Establishment of EBNA-expressing cell lines by infection of Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with different EBV strains. Int J Cancer 17: 161-166.
101. Bernasconi M, Berger C, Sigrist JA, Bonanomi A, Sobek J, et al. (2006) Quantitative profiling of housekeeping and Epstein-Barr virus gene transcription in Burkitt lymphoma cell lines using an oligonucleotide microarray. Virol J 3: 43.